Sort   by:  
 Page size 
UnknownAntibody testing for COVID-19: A report from the National COVID Scientific Advisory Panel.
Not available
S-EPMC7941096 | biostudies-literature
UnknownOmicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses.
Not available
S-EPMC8722586 | biostudies-literature
UnknownPerformance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison.
Not available
S-EPMC7511171 | biostudies-literature
UnknownSARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses.
Not available
S-EPMC8723827 | biostudies-literature
UnknownPara-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses.
Not available
S-EPMC10746705 | biostudies-literature
UnknownSARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination.
Not available
S-EPMC9762734 | biostudies-literature
UnknownCancer LncRNA Census reveals evidence for deep functional conservation of long noncoding RNAs in tumorigenesis.
Not available
S-EPMC7002399 | biostudies-literature
UnknownPathway and network analysis of more than 2500 whole cancer genomes.
Not available
S-EPMC7002574 | biostudies-literature
UnknownCombined burden and functional impact tests for cancer driver discovery using DriverPower.
Not available
S-EPMC7002750 | biostudies-literature
UnknownIntegrative pathway enrichment analysis of multivariate omics data.
Not available
S-EPMC7002665 | biostudies-literature
Sort   by:  
 Page size